GenSight's Project Portfolio Management Solution Chosen by G&W Laboratories to Enhance Product Portfolio Management

Share Article

GenSight, a leader in integrated software for new product and project portfolio management, resource management, Stage-Gate®, and project management, announced today that G&W Laboratories (“G&W”) has selected GenSight’s Software-as-a-Service solution to help it enhance its R&D processes related to the development of innovative new products.

News Image
“G&W chose GenSight because of its integrated capability across one platform, robust functionality that can be easily configured, and superior integration capabilities" Kumar Kantheti, VP of Portfolio Management G&W Laboratories

GenSight, a leader in integrated software for new product and project portfolio management, resource management, Stage-Gate®, and project management, announced today that G&W Laboratories (“G&W”) has selected GenSight’s Software-as-a-Service solution to help it enhance its R&D processes related to the development of innovative new products.

G&W, a world leader and continuous innovator in pharmaceuticals designed to alleviate human suffering, recognized the need to implement advanced technology to enable and integrate portfolio management and project management. G&W selected GenSight’s technology to help them enhance their portfolio and project management processes to further fuel innovation and growth.

Kumar Kantheti, G&W’s Vice President of Portfolio Management said: “G&W chose GenSight because of its integrated capability across one platform, robust functionality that can be easily configured, and superior integration capabilities with the company’s existing business processes and data sources. GenSight’s enterprise solution will help G&W further enhance the efficiency of R&D, while prioritizing the most innovative and valuable initiatives and optimizing resource allocation across the portfolio.”

GenSight provides market-leading enterprise portfolio management software and support to both mid-sized and large corporations to help manage complex innovation, business, process, technology and capital investment programs. A market leader in Product and Project Portfolio Management, Corporate Portfolio Management, and Capital Portfolio Management, GenSight’s technology enables critical decision making on where to invest, which programs and projects to prioritize, and how to execute and bring those programs and projects to value most profitably. From idea to delivery GenSight’s comprehensive solution will help G&W accelerate successful product development, time-to-market, and value creation.

The latest version of its enterprise project portfolio management solution, GenSight v9.2, is highly scalable, provides a range of deployment options including Cloud, On-Premise and Hybrid, and comes fully-featured including dynamic HTML5 charts and graphics. GenSight’s rapidly growing client roster includes many Life Science companies, as well as leading brands in the Consumer, Chemical, and Energy Industries.

“The GenSight team is excited to work with G&W Labs as it has a history of continuous innovation and creating consumer and value” said Michael Menard, President and Co-Founder of GenSight. “G&W has developed an impressive, integrated portfolio and project management process, and we are exited G&W has selected GenSight’s technology to enhance its ability to prioritize and execute the right innovations to drive capital efficient profitable growth.”

About The GenSight Group

GenSight is the world’s leading Enterprise Portfolio Management solution today. It is the industry’s only complete platform for complex Portfolio Management, Resource Optimization, and Stage-Gate® Management. Our total solution integrates business process consulting, best-of-breed technology, and implementation methodology.

The Forrester Wave ™ recently highlighted GenSight as a leader for Portfolio Management and placed the company in the Leaders category. Just some of the organizations deploying the GenSight solution are Johnson and Johnson, Suncor Energy, Pfizer, Natura, GlaxoSmithKline and Integra LifeSciences.

GenSight is an official participant of the United Nations Global Compact, enabling leading corporations around the globe to improve their fundamental ability to create a more sustainable future by optimizing the allocation of limited resource to generate the greatest good for the environment, shareholders and communities.

GENSIGHT: THE VALUE OF INSIGHT http://www.gensight.com

About G&W Laboratories

Since 1919, G&W Laboratories has developed, manufactured, and marketed pharmaceuticals designed to alleviate human suffering. We serve our customers by providing quality pharmaceuticals, valuable services, and timely information while remaining responsive to an ever-changing marketplace. We accomplish these objectives by building upon our unique history, while anticipating the future needs of the marketplace and responding quickly. For more information, please visit http://www.gwlabs.com/.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Samantha Huntington
GenSight
+1 239 300 3407
Email >
@GenSightGroup
since: 07/2012
Follow >
GenSight

Visit website